1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
3 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -32.27K | 4.87% |
| Net profit | -2.65M | 24.12% |
| EBITDA | -2.62M | 24.58% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €705.94K |
Number of shares | 597.01K |
52-week high/low | €11.77 - €1.01 |
| Dividends | No |
Beta | 1.11 |
P/E ratio | -0.08 |
PEG ratio | 0.00 |
P/B ratio | 0.68 |
P/S ratio | 0.00 |
Company profile
| Name | Enveric Biosciences |
| CEO | Joseph Edward Tucker |
| Employees | 6 |
Discover assets
Shareholders of Enveric Biosciences also invest in the following assets
